Beckman Coulter bags Agencourt Bioscience
This article was originally published in The Gray Sheet
Executive Summary
Fullerton, Calif.-based biomedical testing firm says purchase of Agencourt for $100 mil., plus up to $40 mil. of contingent payments through 2007, will give it a sustainable share of the genomic testing market. Agencourt's solid-phase reversible immobilization (SPRI) technology, which isolates and purifies RNA and DNA, is used routinely with Beckman's Biomek automated liquid handling system...